Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose prednisolone added to existing antirheumatic therapy in elderly patients with rheumatoid arthritis
NL-OMON47583Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in rheumatoid arthritis (RA) comparing Prednisolone add-on with Placebo add-on (2 arms). Primary endpoints: Time-averaged disease activity, Radiographic damage progression and 4 more. Started Jun 2016; status: active, not recruiting.
02
Drugs
prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON47583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47583.